Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E3 and lactobacilli vaginal suppository in transgender women with neovaginas
TCTR20240515007Phase 4Unknown
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of estriol in neovaginal symptoms, Vaginal dysbiosis, sponsored by Ratchadaphiseksomphot Endowment Fund. Status: unknown.
02
Drugs
estriol
03
Conditions
neovaginal symptomsVaginal dysbiosis
Beyond the preview
Go deeper on TCTR20240515007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240515007.